Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

C O N M E D Corp (CNMD)

C O N M E D Corp (CNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,230,276
  • Shares Outstanding, K 30,834
  • Annual Sales, $ 1,375 M
  • Annual Income, $ 47,060 K
  • EBIT $ 103 M
  • EBITDA $ 183 M
  • 60-Month Beta 0.91
  • Price/Sales 0.93
  • Price/Cash Flow 5.75
  • Price/Book 1.24

Options Overview Details

View History
  • Implied Volatility 53.43% (+4.48%)
  • Historical Volatility 36.04%
  • IV Percentile 65%
  • IV Rank 47.40%
  • IV High 74.17% on 04/11/25
  • IV Low 34.73% on 09/17/25
  • Expected Move (DTE 11) 2.60 (6.60%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 75
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 1,737
  • Open Int (30-Day) 1,222
  • Expected Range 36.81 to 42.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.82
  • Number of Estimates 3
  • High Estimate 0.83
  • Low Estimate 0.81
  • Prior Year 0.95
  • Growth Rate Est. (year over year) -13.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.88 +4.04%
on 03/09/26
47.08 -16.29%
on 02/26/26
-2.26 (-5.42%)
since 02/09/26
3-Month
35.37 +11.42%
on 01/29/26
47.08 -16.29%
on 02/26/26
+0.42 (+1.08%)
since 12/09/25
52-Week
35.37 +11.42%
on 01/29/26
64.87 -39.25%
on 03/10/25
-23.33 (-37.19%)
since 03/07/25

Most Recent Stories

More News
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know

PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know

TNDM : 20.88 (-1.23%)
PACB : 1.3900 (+0.72%)
MRNA : 55.74 (+6.13%)
CNMD : 39.41 (-1.23%)
QDEL : 19.86 (-4.66%)
1 Profitable Stock for Long-Term Investors and 2 We Ignore

1 Profitable Stock for Long-Term Investors and 2 We Ignore

WCN : 171.73 (+0.93%)
ORLY : 94.61 (+0.01%)
CNMD : 39.41 (-1.23%)
3 Reasons CNMD is Risky and 1 Stock to Buy Instead

3 Reasons CNMD is Risky and 1 Stock to Buy Instead

CNMD : 39.41 (-1.23%)
5 Must-Read Analyst Questions From CONMED’s Q4 Earnings Call

5 Must-Read Analyst Questions From CONMED’s Q4 Earnings Call

CNMD : 39.41 (-1.23%)
1 Cash-Producing Stock to Target This Week and 2 We Find Risky

1 Cash-Producing Stock to Target This Week and 2 We Find Risky

MCHP : 65.00 (+0.36%)
CNMD : 39.41 (-1.23%)
YOU : 46.23 (+0.11%)
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook

CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook

CNMD : 39.41 (-1.23%)
Conmed: Q4 Earnings Snapshot

Conmed: Q4 Earnings Snapshot

CNMD : 39.41 (-1.23%)
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars

CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars

CNMD : 39.41 (-1.23%)
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights ...

CNMD : 39.41 (-1.23%)
CONMED Earnings: What To Look For From CNMD

CONMED Earnings: What To Look For From CNMD

CNMD : 39.41 (-1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered...

See More

Key Turning Points

3rd Resistance Point 41.80
2nd Resistance Point 40.71
1st Resistance Point 40.06
Last Price 39.41
1st Support Level 38.32
2nd Support Level 37.23
3rd Support Level 36.58

See More

52-Week High 64.87
Fibonacci 61.8% 53.60
Fibonacci 50% 50.12
Fibonacci 38.2% 46.64
Last Price 39.41
52-Week Low 35.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar